1. Executive Summary
2. Research Methodology
3. Peripheral Vascular Disease
3.1 Overview
3.2 Types of PVD
3.2.1 Functional PVD
3.2.2 Organic PVD
3.4 Diagnosis of PVD
3.5 Treatment of PVD
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Devices
4.2.2 Market Share by Drugs
4.2.3 Market Share by Type of Disease
4.2.4 Market Share by Region
5. Country Analysis
5.1 The US
5.1.1 Market Sizing (Actual & Forecasted)
5.1.2 Market Share by Procedure
5.1.3 Market Share by Device
5.2 China
5.2.1 Market Sizing (Actual & Forecasted)
5.3 Japan
5.3.1 Market Sizing (Actual & Forecasted)
6. Market Segmentation
6.1 Peripheral Vascular Stent
6.1.1 Overview
6.1.2 Market Sizing (Actual & Forecasted)
6.1.3 Market Share by Segment
6.1.4 Market Share by Region
6.2 Drug-Coated Balloon (DCB)
6.2.1 Overview
6.2.2 Market Sizing (Actual & Forecasted)
6.3 Atherectomy Devices
6.3.1 Overview
6.3.2 Market Sizing (Actual & Forecasted)
6.4 Drug Eluting Stent (DES)
6.4.1 Overview
6.4.2 Market Sizing (Actual & Forecasted)
6.5 PTA Balloon Catheter
6.5.1 Overview
6.5.2 Market Sizing (Actual & Forecasted)
7. Pricing Analysis
8. Market Dynamics
8.1 Industry Trends & Development
8.1.1 Precision Vascular Robotics
8.1.2 Advent of Bioresorbable stent
8.1.3 Novel ?3-D? Stent System
8.1.4 Specialty Stents for PAD
8.1.5 Other New Technologies
8.2 Growth Drivers
8.2.1 Growing Geriatric Population
8.2.2 High Restenosis Rates
8.2.3 Rising Incidences of PAD
8.2.4 Increasing Public Awareness
8.3 Challenges
8.3.1 Strict Regulatory Compliance
8.3.2 High Cost of Treatment
8.3.3 Others
9. Competitive Landscape
9.1 Product Portfolio
9.1.1 Market Share by Competitors
10. Company Profiles
10.1 Boston Scientific
10.2 Medtronic plc
10.3 Abbott Laboratories
10.4 C.R. Bard